Your Article Summary
See Latest ArticlesSafety of Selective Serotonin Reuptake Inhibitors in Pregnancy
CNS Drugs, 06/15/09
Alwan S et al. - Maternal SSRI treatment during the first trimester has been implicated in increased risks of birth defects, specifically cardiac abnormalities, in the infant, whereas third-trimester treatment has been linked to various neonatal complications, including symptoms of neonatal withdrawal and toxicity, prematurity, low birth weight and persistent pulmonary hypertension of the newborn. Although data on neurobehavioural and long-term cognitive problems among children of women who were treated with SSRIs during pregnancy remain limited, the possibility of such functional abnormalities is an additional concern. On the other hand, untreated maternal depression also carries serious risks for both the mother and the baby, and SSRIs are one of the best available treatments. Thus, pregnant women who require treatment for depression and their physicians often face a difficult choice regarding the use of SSRIs.
Related Articles
Effects of Selective Serotonin Reuptake Inhibitor on Treating Tinnitus in Patients Stratified for Presence of Depression or Anxiety
Audiology & Neuro-Otology, 10/23/09
Relevance Score: 87%
Photosensitivity associated with selective serotonin reuptake inhibitors
Clinical and Experimental Dermatology, 10/16/09
Relevance Score: 87%
Neonatal S100B Protein Levels After Prenatal Exposure to Selective Serotonin Reuptake Inhibitors
Pediatrics, 10/15/09
Relevance Score: 87%
Selective Serotonin Reuptake Inhibitor Exposure In Utero and Pregnancy Outcomes
Archives of Pediatrics and Adolescent Medicine, 10/08/09
Relevance Score: 87%
Vilazodone, a novel dual-acting serotonergic antidepressant for managing major depression
Expert Opinion on Investigational Drugs, 10/02/09
Relevance Score: 87%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Formulary , 12/16/09
Phenylephrine but not Ephedrine Reduces Frontal Lobe Oxygenation Following Anesthesia-Induced Hypotension
Neurocritical Care , 12/16/09
Acetazolamide and midazolam act synergistically to inhibit neuropathic pain
Pain, 12/16/09